OnabotulinumtoxinA treatment of moderate to severe glabellar lines in Chinese subjects after laser therapy: A prospective, open-label, noncomparative study

Yan WuDepartment of Dermatology, Peking University First Hospital, Beijing, ChinaCorrespondence[email protected]

Zhong LuDepartment of Dermatology, Huashan Hospital, Shanghai, China

Yong XieDepartment of Dermatology, Peking Union Medical College Hospital, Beijing, China

Wei ZhangMedical Beauty Center, Shanghai Dermatology Hospital, Shanghai, China

Xiangdong ChenDermatological Department, Shanghai Ninth People’s Hospital, Shanghai, China

Yuling ShiDepartment of Dermatology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, China

Qin LiDepartment of Plastic Surgery and Laser Center, General Hospital of Guangzhou Military Command of PLA, Guang Dong Province, China

Michael HalsteadAllergan plc, Gordon, NSW, Australia

John D RogersDivision of Global Medical Affairs, Galderma, Uppsala, Sweden

Michael SilberbergAllergan plc, Marlow, UK

Your download is now in progress and you may close this window